BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20812782)

  • 1. Interrogation of nucleotide excision repair capacity: impact on platinum-based cancer therapy.
    Earley JN; Turchi JJ
    Antioxid Redox Signal; 2011 Jun; 14(12):2465-77. PubMed ID: 20812782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin.
    Stubbert LJ; Smith JM; McKay BC
    BMC Cancer; 2010 May; 10():207. PubMed ID: 20470425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
    Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
    Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
    Gentile F; Tuszynski JA; Barakat KH
    J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
    Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K
    Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance.
    Wang Z; Xu Z; Zhu G
    Angew Chem Int Ed Engl; 2016 Dec; 55(50):15564-15568. PubMed ID: 27736029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy?
    Bowden NA
    Cancer Lett; 2014 May; 346(2):163-71. PubMed ID: 24462818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts.
    Reardon JT; Vaisman A; Chaney SG; Sancar A
    Cancer Res; 1999 Aug; 59(16):3968-71. PubMed ID: 10463593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.
    Reed E
    Cancer Treat Rev; 1998 Oct; 24(5):331-44. PubMed ID: 9861196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide excision repair by mutant xeroderma pigmentosum group A (XPA) proteins with deficiency in interaction with RPA.
    Saijo M; Takedachi A; Tanaka K
    J Biol Chem; 2011 Feb; 286(7):5476-83. PubMed ID: 21148310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability.
    Jordheim LP; Cros-Perrial E; Matera EL; Bouledrak K; Dumontet C
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):817-24. PubMed ID: 25115435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERCC2/XPD Lys751Gln alter DNA repair efficiency of platinum-induced DNA damage through P53 pathway.
    Zhang G; Guan Y; Zhao Y; van der Straaten T; Xiao S; Xue P; Zhu G; Liu Q; Cai Y; Jin C; Yang J; Wu S; Lu X
    Chem Biol Interact; 2017 Feb; 263():55-65. PubMed ID: 28027876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Nucleotide Excision Repair in Cisplatin Resistance.
    Duan M; Ulibarri J; Liu KJ; Mao P
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoactivated DNA analogs of substrates of the nucleotide excision repair system and their interaction with proteins of NER-competent HeLa cell extract.
    Petruseva IO; Tikhanovich IS; Maltseva EA; Safronov IV; Lavrik OI
    Biochemistry (Mosc); 2009 May; 74(5):491-501. PubMed ID: 19538122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XPA: DNA Repair Protein of Significant Clinical Importance.
    Borszéková Pulzová L; Ward TA; Chovanec M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32235701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
    Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
    BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XPA protein as a limiting factor for nucleotide excision repair and UV sensitivity in human cells.
    Köberle B; Roginskaya V; Wood RD
    DNA Repair (Amst); 2006 May; 5(5):641-8. PubMed ID: 16413230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human HMGB1 directly facilitates interactions between nucleotide excision repair proteins on triplex-directed psoralen interstrand crosslinks.
    Lange SS; Reddy MC; Vasquez KM
    DNA Repair (Amst); 2009 Jul; 8(7):865-72. PubMed ID: 19446504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembled Lipid Nanoparticles for Ratiometric Codelivery of Cisplatin and siRNA Targeting XPF to Combat Drug Resistance in Lung Cancer.
    Li C; Li T; Huang L; Yang M; Zhu G
    Chem Asian J; 2019 May; 14(9):1570-1576. PubMed ID: 30843348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair.
    Kudo K; Gavin E; Das S; Amable L; Shevde LA; Reed E
    Oncogene; 2012 Nov; 31(44):4718-24. PubMed ID: 22266871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.